Stock ENBI ENTHEON BIOMEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Market Closed - Canadian Securities Exchange
Other stock markets
 14:30:00 05/07/2024 BST 		5-day change 1st Jan Change
0.075 CAD -51.61% Intraday chart for Entheon Biomedical Corp. -51.61% -25.00%
07-04 Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2024 CI
04-29 Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2024
CI
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024
CI
Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding
CI
Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding
CI
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2023
CI
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023
CI
Entheon Biomedical Corp. Announces Termination of Andrew Hegle as Chief Science Officer
CI
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023
CI
Heading Health Inc. announced that it has received $4.5 million in funding from a group of investors
CI
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2023
CI
Entheon Biomedical Corp. Announces Termination of Consulting Agreement with Cybin
CI
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt
CI
Entheon Biomedical Corp. Announces Resignation of Ruth Chun as Director
CI
Entheon Biomedical Corp. Announces CFO Changes
CI
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022
CI
Entheon Biomedical Corp. Closes Patient Enrolment in its Clinical Research Study EBIQ-101
CI
Entheon Biomedical : CFO Certification
PU
Entheon Biomedical : CEO Certification
PU
Entheon Biomedical : Quarterly Report
PU
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENBI Stock
  4. News Entheon Biomedical Corp.